Future Perspectives for Uterine Cervical Cancer Treatment based on Integrative Genomic and Molecular Characterizations
- PMID: 28351082
- PMCID: PMC10309487
- DOI: 10.1055/s-0037-1601399
Future Perspectives for Uterine Cervical Cancer Treatment based on Integrative Genomic and Molecular Characterizations
Figures
References
-
- Ferlay J, Soerjomataram I, Ervik Met al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet] Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed on 01/02/2017
-
- Siegel R L, Miller K D, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67(01):7–30. - PubMed
-
- Fundação Oncocentro de São Paulo.Boletins RHCAvailable at: http://www.fosp.saude.sp.gov.br/publicacoes/boletinsrhc
-
- Kim J Y, Byun S J, Kim Y S, Nam J H. Disease courses in patients with residual tumor following concurrent chemoradiotherapy for locally advanced cervical cancer. Gynecol Oncol. 2017;144(01):34–39. - PubMed
-
- Ferrandina G, Margariti P A, Smaniotto D et al.Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery. Gynecol Oncol. 2010;119(03):404–410. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical